| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |